Delivery Order SPE2DB22D9206-SPE2DB26FV5BF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $16,701.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vials. The award was issued on October 16, 2025, with an ultimate completion date of November 6, 2025, under firm fixed-price terms with no set-aside designation. This delivery order represents one of numerous recent awards issued to DMS...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $36,196.84 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in one-dose vial format. This firm fixed-price delivery order was issued on October 24, 2025, with an ultimate completion date of October 27, 2025, and carries no set-aside designation, indicating the award was made through...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in single-dose vial format. This $1,113.42 firm fixed-price delivery order was issued on October 29, 2025, with an ultimate completion date of November 20, 2025, and carries no set-aside designation. The award leverages DMS Pharmaceutical Group's position as a regional prime...
- The Defense Logistics Agency awarded a delivery order valued at $22,270.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in one-dose vials. The award, issued on October 27, 2025, is structured as a firm fixed-price delivery order with an ultimate completion date of November 18, 2025. No set-aside designation was utilized in this competitive procurement. DMS Pharmaceutical...
- The Defense Logistics Agency awarded a $27,835.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in one-dose vial format. The delivery order was issued on October 16, 2025, with an ultimate completion date of November 6, 2025, and carries no set-aside designation, indicating DMS Pharmaceutical Group competed successfully in unrestricted...
- The Defense Logistics Agency awarded a delivery order valued at $5,567.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vial format. The contract utilizes firm fixed-price pricing with an ultimate completion date of November 13, 2025, and was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal...
- The Defense Logistics Agency awarded a delivery order valued at $8,350.65 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (Yellow Fever Vaccine) in one-dose vials. The contract, issued on July 11, 2025, with an ultimate completion date of August 1, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite...
- The Defense Logistics Agency awarded a $1,113.42 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for YF-VAX (yellow fever vaccine) in single-dose vials on October 20, 2025. The delivery order, with an ultimate completion date of November 10, 2025, carries no set-aside designation, allowing the woman-owned small business to compete directly against other qualified vendors. DMS Pharmaceutical Group, headquartered in Park Ridge, Illinois, is the sole awardee with no identified...
- The Defense Logistics Agency awarded a delivery order valued at $2,783.80 to DMS Pharmaceutical Group Inc. for YF-VAX (Yellow Fever Vaccine) 1 dose vials on October 30, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected under a firm fixed-price contract with an ultimate completion date of November 21, 2025. This delivery order was issued without a set-aside designation, reflecting the company's competitive...
- The Defense Logistics Agency awarded a delivery order valued at $1,670.13 to DMS Pharmaceutical Group Inc. on October 23, 2025, for YF-VAX (yellow fever vaccine) in one-dose vials to be delivered to Park Ridge, Illinois, with completion by November 14, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected under a firm fixed-price delivery order with no set-aside designation. The award reflects the company's...
- SPE2DB22D9206Indefinite Delivery Contract
- SPE2DB22D9206-SPE2DB26FV5BFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,567.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (Yellow Fever vaccine) in single-dose vial format. This delivery order, issued on October 28, 2025, represents a firm fixed-price procurement with an ultimate completion date of November 19, 2025. The award includes no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group Inc. serves as a critical supplier within the federal pharmaceutical supply chain, with demonstrated expertise in distributing a comprehensive range of pharmaceutical products and medical consumables to Department of Defense facilities. This delivery order was issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy that establishes multiple regional prime vendor contractors. The underlying IDC, valued at $499,999,999 and effective through December 31, 2036, authorizes the issuance of firm fixed-price delivery orders for pharmaceutical products and medical consumables to support military healthcare operations globally. DMS Pharmaceutical Group's established performance on numerous delivery orders issued between October 2 and October 15, 2025 demonstrates its capability to fulfill the specialized pharmaceutical requirements of the Department of Defense medical system, positioning the company as a significant supplier within the federal military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 10/28/25 |